X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (107) 107
female (81) 81
male (81) 81
diabetes (80) 80
cardiac & cardiovascular systems (71) 71
aged (68) 68
diabetes mellitus (64) 64
middle aged (64) 64
mortality (61) 61
risk factors (58) 58
abridged index medicus (51) 51
cardiovascular disease (43) 43
heart failure (40) 40
endocrinology & metabolism (37) 37
glucose (37) 37
outcomes (37) 37
heart attacks (35) 35
type 2 diabetes (34) 34
cardiovascular (31) 31
risk (30) 30
insulin (29) 29
heart attack (28) 28
hospitalization (28) 28
cardiac patients (27) 27
clinical trials (27) 27
analysis (26) 26
care and treatment (25) 25
drug therapy (25) 25
myocardial infarction (25) 25
treatment outcome (25) 25
hemoglobin (24) 24
hypoglycemic agents - therapeutic use (24) 24
patients (24) 24
registries (24) 24
united states - epidemiology (24) 24
adult (23) 23
association (23) 23
cardiovascular diseases (23) 23
diabetes mellitus, type 2 - drug therapy (22) 22
follow-up studies (22) 22
prevalence (21) 21
dextrose (20) 20
death (19) 19
heart diseases (19) 19
mellitus (19) 19
cardiology (18) 18
diabetes mellitus, type 2 - complications (17) 17
myocardial infarction - complications (17) 17
time factors (17) 17
blood glucose - metabolism (16) 16
disease (16) 16
hypoglycemia (16) 16
risk assessment (16) 16
diabetes mellitus, type 2 - blood (15) 15
health risk assessment (15) 15
management (15) 15
myocardial infarction - mortality (15) 15
myocardial-infarction (15) 15
patient outcomes (15) 15
cholesterol (14) 14
diabetes therapy (14) 14
diabetics (14) 14
health aspects (14) 14
medical research (14) 14
studies (14) 14
blood pressure (13) 13
clinical medicine (13) 13
cohort studies (13) 13
heart (13) 13
hospitals (13) 13
internal medicine (13) 13
medicine, general & internal (13) 13
peripheral vascular disease (13) 13
prognosis (13) 13
prospective studies (13) 13
retrospective studies (13) 13
therapy (13) 13
united states (13) 13
acute coronary syndromes (12) 12
aged, 80 and over (12) 12
anemia (12) 12
hyperglycemia (12) 12
research (12) 12
sodium (12) 12
cardiovascular diseases - prevention & control (11) 11
diabetes mellitus - epidemiology (11) 11
diabetes mellitus, type 2 - epidemiology (11) 11
glycosylated hemoglobin (11) 11
heart-failure (11) 11
hyperkalemia (11) 11
incidence (11) 11
metformin (11) 11
percutaneous coronary intervention (11) 11
prevention (11) 11
statins (11) 11
blood glucose - analysis (10) 10
epidemiology (10) 10
glycated hemoglobin a - metabolism (10) 10
hypoglycemic agents - administration & dosage (10) 10
hypoglycemic agents - adverse effects (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 21, pp. 1995 - 2008
In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients... 
NEPRILYSIN INHIBITION | OUTCOMES | COTRANSPORTER 2 INHIBITORS | MECHANISM | EMPAGLIFLOZIN | MEDICINE, GENERAL & INTERNAL | Glycated Hemoglobin A - analysis | Humans | Middle Aged | Ventricular Dysfunction, Left - complications | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Drug Therapy, Combination | Benzhydryl Compounds - therapeutic use | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Heart Failure - complications | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Kaplan-Meier Estimate | Stroke Volume - drug effects | Combined Modality Therapy | Hospitalization | Heart Failure - drug therapy | Cardiovascular Agents - therapeutic use | Diabetes Mellitus, Type 2 - blood | Ventricular Dysfunction, Left - drug therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Measurement | Heart failure | Dapagliflozin | Patient outcomes | Physiological aspects | Cardiac output | Drug therapy | Testing | Intravenous administration | Renal function | Clinical trials | Hypoglycemia | Evidence-based medicine | Clinical outcomes | Sodium | Hemoglobin | Patient safety | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Ejection fraction | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Diabetes care, ISSN 1935-5548, 2015, Volume 38, Issue 9, pp. 1777 - 1803
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 21, pp. 1972 - 1982
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 18, pp. 1720 - 1732
Journal Article
Circulation, ISSN 0009-7322, 07/2017, Volume 136, Issue 3, pp. 249 - 259
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2018, Volume 71, Issue 22, pp. 2497 - 2506
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2013, Volume 61, Issue 4, pp. S12 - S23
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 2018, Volume 20, Issue 8, pp. 1983 - 1987
The multinational, observational CVD‐REAL study recently showed that initiation of sodium‐glucose co‐transporter‐2 inhibitors (SGLT‐2i) was associated with... 
cardiovascular disease | type 2 diabetes | SGLT2 inhibitor | observational study | ENDOCRINOLOGY & METABOLISM | RISK | MECHANISMS | INHIBITORS | REG OUTCOME TRIAL | United States - epidemiology | Myocardial Infarction - epidemiology | Prevalence | Follow-Up Studies | Humans | Middle Aged | Stroke - complications | Male | Risk | Myocardial Infarction - therapy | Comparative Effectiveness Research | Diabetic Cardiomyopathies - prevention & control | Female | Stroke - epidemiology | Diabetic Cardiomyopathies - therapy | Diabetic Angiopathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Insurance, Health | Scandinavian and Nordic Countries - epidemiology | Stroke - therapy | Hypoglycemic Agents - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Stroke - prevention & control | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Diabetic Neuropathies - prevention & control | Medical Records | Proportional Hazards Models | Diabetic Angiopathies - therapy | Myocardial Infarction - complications | Propensity Score | Diabetic Neuropathies - therapy | Diabetic Cardiomyopathies - epidemiology | Intention to Treat Analysis | Diabetic Neuropathies - epidemiology | Diabetic Angiopathies - epidemiology | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Cohort Studies | Stroke (Disease) | Medical records | Glucose | Drug therapy | Stroke patients | Dextrose | Myocardial infarction | Glucose transporter | Cerebral infarction | Stroke | Heart attacks | Clinical trials | Regression analysis | Patients | Sodium | Diabetes | Health risk assessment | Heart diseases | Brief Report | Brief Reports
Journal Article
Journal Article